Saposin A: Second Cerebrosidase Activator Protein

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1989 May 1

PMID 2717620

Citations 45

Authors

S Morimoto

B M Martin

Y Yamamoto

K A Kretz

J S OBrien

Y Kishimoto

Affiliations

Soon will be listed here.

Abstract

Saposin A, a heat-stable 16-kDa glycoprotein, was isolated from Gaucher disease spleen and purified to homogeneity. Chemical sequencing from its amino terminus and of peptides obtained by digestion with protease from Staphylococcus aureus strain V-8 demonstrated that saposin A is derived from proteolytic processing of domain 1 of its precursor protein, prosaposin. Processing of prosaposin (70 kDa) also generates three other previously reported saposin proteins, B, C, and D, from its second, third, and fourth domains. Similar to saposin C, saposin A stimulates the hydrolysis of 4-methylumbelliferyl beta-glucoside and glucocerebroside by beta-glucosylceramidase and of galactocerebroside by beta-galactosylceramidase, mainly by increasing the maximal velocity of both reactions. Saposin A is as active as saposin C in these reactions. Saposin A has no significant effect on other sphingolipid and 4-methylumbelliferyl glycoside hydrolases tested. Saposin A has two potential glycosylation sites that appear to be glycosylated. After deglycosylation, saposin A had a subunit molecular mass of 10 kDa and was as active as native saposin A. However, reduction and alkylation abolished the activation. A three-dimensional model comparing saposins A and C reveals significant sequence homology between them, especially preservation of conserved acidic and basic residues in their middle regions. Each appears to possess a conformationally rigid hydrophobic pocket stabilized by three internal disulfide bridges, with amphipathic helical regions interrupted by helix breakers.

Citing Articles

The spectrum of lysosomal stress and damage responses: from mechanosensing to inflammation.

Scott O, Saran E, Freeman S EMBO Rep. 2025; .

PMID: 40016424 DOI: 10.1038/s44319-025-00405-9.

Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes.

Miyahara Y, Takano S, Sogawa K, Tomizawa S, Furukawa K, Takayashiki T Cancer Sci. 2022; 113(8):2548-2559.

PMID: 35633503 PMC: 9357616. DOI: 10.1111/cas.15444.

Sphingolipid lysosomal storage diseases: from bench to bedside.

Abed Rabbo M, Khodour Y, Kaguni L, Stiban J Lipids Health Dis. 2021; 20(1):44.

PMID: 33941173 PMC: 8094529. DOI: 10.1186/s12944-021-01466-0.

Genetic Analysis of Prosaposin, the Lysosomal Storage Disorder Gene in Parkinson's Disease.

Chen Y, Gu X, Ou R, Zhang L, Hou Y, Liu K Mol Neurobiol. 2020; 58(4):1583-1592.

PMID: 33219486 DOI: 10.1007/s12035-020-02218-4.

Progranulin deficiency leads to reduced glucocerebrosidase activity.

Zhou X, Paushter D, Pagan M, Kim D, Nunez Santos M, Lieberman R PLoS One. 2019; 14(7):e0212382.

PMID: 31291241 PMC: 6619604. DOI: 10.1371/journal.pone.0212382.

References

MEHL E, JATZKEWITZ H . [A cerebrosidesulfatase from swine kidney]. Hoppe Seylers Z Physiol Chem. 1964; 339(1):260-76. View

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

Waxdal M, Konigsberg W, HENLEY W, Edelman G . The covalent structure of a human gamma G-immunoglobulin. II. Isolation and characterization of the cyanogen bromide fragments. Biochemistry. 1968; 7(5):1959-66. DOI: 10.1021/bi00845a046. View

Ho M, OBrien J . Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro. Proc Natl Acad Sci U S A. 1971; 68(11):2810-3. PMC: 389531. DOI: 10.1073/pnas.68.11.2810. View

Suzuki Y, Suzuki K . Specific radioactive labeling of terminal n-acetylgalactosamine of glycosphingolipids by the galactose oxidase-sodium borohydride method. J Lipid Res. 1972; 13(5):687-90. View

Houmard J, Drapeau G . Staphylococcal protease: a proteolytic enzyme specific for glutamoyl bonds. Proc Natl Acad Sci U S A. 1972; 69(12):3506-9. PMC: 389807. DOI: 10.1073/pnas.69.12.3506. View

Ho M, OBrien J, RADIN N, Erickson J . Glucocerebrosidase: reconstitution of activity from macromolecular components. Biochem J. 1973; 131(1):173-6. PMC: 1177451. DOI: 10.1042/bj1310173. View

Norden A, OBrien J . Ganglioside GM1 beta-galactosidase: studies in human liver and brain. Arch Biochem Biophys. 1973; 159(1):383-92. DOI: 10.1016/0003-9861(73)90465-7. View

Li S, Wan C, Mazzotta M, Li Y . Requirement of an activator for the hydrolysis of sphingoglycolipids by glycosidases of human liver. Carbohydr Res. 1974; 34(1):189-93. DOI: 10.1016/s0008-6215(00)80383-3. View

10.

Fischer G, JATZKEWITZ H . The activator of cerebroside sulphatase. Purification from human liver and identification as a protein. Hoppe Seylers Z Physiol Chem. 1975; 356(5):605-13. DOI: 10.1515/bchm2.1975.356.1.605. View

11.

Li S, Li Y . An activator stimulating the enzymic hydrolysis of sphingoglycolipids. J Biol Chem. 1976; 251(4):1159-63. View

12.

Peters S, Coyle P, Coffee C, Glew R . Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen. J Biol Chem. 1977; 252(2):563-73. View

13.

OBrien J, Norden G, Miller A, Frost R, Kelly T . Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts. Clin Genet. 1977; 11(3):171-83. DOI: 10.1111/j.1399-0004.1977.tb01296.x. View

14.

Furbish F, Blair H, Shiloach J, Pentchev P, Brady R . Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration. Proc Natl Acad Sci U S A. 1977; 74(8):3560-3. PMC: 431631. DOI: 10.1073/pnas.74.8.3560. View

15.

Fischer G, JATZKEWITZ H . The activator of cerebroside-sulphatase. A model of the activation. Biochim Biophys Acta. 1978; 528(1):69-76. DOI: 10.1016/0005-2760(78)90053-x. View

16.

Berent B, RADIN N . beta-Glucosidase activator protein from bovine spleen ("coglucosidase"). Arch Biochem Biophys. 1981; 208(1):248-60. DOI: 10.1016/0003-9861(81)90147-8. View

17.

Stevens R, Fluharty A, Kihara H, Kaback M, Shapiro L, Marsh B . Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy. Am J Hum Genet. 1981; 33(6):900-6. PMC: 1685162. View

18.

RADIN N, Berent S . Protein activator (coglucosidase) for the hydrolysis of beta-glucosides. Methods Enzymol. 1982; 83:596-603. DOI: 10.1016/0076-6879(82)83057-7. View

19.

Wenger D, Sattler M, Roth S . A protein activator of galactosylceramide beta-galactosidase. Biochim Biophys Acta. 1982; 712(3):639-49. DOI: 10.1016/0005-2760(82)90293-4. View

20.

Li S, Kihara H, Serizawa S, Li Y, Fluharty A, Mayes J . Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and.... J Biol Chem. 1985; 260(3):1867-71. View